Earnings Feed
Start Free
Home/Filings/4/0001140361-12-030688
4//SEC Filing

Cheong Kwang Soo 4

Accession 0001140361-12-030688

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 4:14 PM ET

Size

13.3 KB

Accession

0001140361-12-030688

Insider Transaction Report

Form 4
Period: 2012-06-18
REXAHN PHARMACEUTICALS, INC.RNN
Cheong Kwang Soo
Director
Transactions
  • Award

    Stock Options (right-to-buy)

    2012-06-18+20,000→ 20,000 total
    Exercise: $0.38Exp: 2022-06-18→ Common Stock (20,000 underlying)
Holdings

  • Common Stock

    3,000

  • Stock Options (right-to-buy)

    Exercise: $1.17From: 2011-06-14Exp: 2020-06-14→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.28From: 2010-06-01Exp: 2019-06-01→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.25From: 2012-06-06Exp: 2021-06-06→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $3.24From: 2009-06-30Exp: 2018-06-30→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
    20,000

  • Stock Options (right-to-buy)

    Exercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying)
    20,000
Footnotes (1)
  • [F1]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001361686

Filing Metadata

Form type
4
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:14 PM ET
Size
13.3 KB
View on SEC.gov